Dr. Reddy’s to expand GLP-1 portfolio with focus on obesity and diabetes drug markets
With Novo Nordisk’s patent on semaglutide set to expire in India, Dr Reddy’s is among the forerunners trying to bring the ...
homestolove.com.au1h
Who our favourite former contestants predict will win The Block 2024 auction
Now so more than ever, The Block auctions are really the perfect combination of beautiful architecture, the right auction ...
Titan Company shares: Goldman Sachs, Jefferies cut target prices on Tata stock
We maintain our Buy rating," Goldman Sachs said. Titan Company said its net profit for Q2 fell 23 per cent to Rs 704 crore ...
Indiatimes5m
Reliance Industries Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
BHEL shares zoomed 10% after reporting a net profit of Rs 106 crore in Q2FY25, compared to a loss of Rs 63 crore in Q2FY24. Revenue from operations stood at Rs 6,584 crore, up 28% YoY. BHEL shares ...